Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00821483Phase 3Completed
A Phase 3 trial of frovatriptan in migraine, sponsored by SK Chemicals. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00821483.